Cargando…
Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR
DNA damage response (DDR) is a highly conserved genome surveillance mechanism that preserves cell viability in the presence of chemotherapeutic drugs. Hence, small molecules that inhibit DDR are expected to enhance the anti-cancer effect of chemotherapy. Through a recent chemical library screen, we...
Autores principales: | Wang, Fangfang, Jin, Sora, Mayca Pozo, Franklin, Tian, Danmei, Tang, Xiyang, Dai, Yi, Yao, Xinsheng, Tang, Jinshan, Zhang, Youwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072232/ https://www.ncbi.nlm.nih.gov/pubmed/35530159 http://dx.doi.org/10.1016/j.apsb.2021.08.025 |
Ejemplares similares
-
Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
por: Wang, Fangfang, et al.
Publicado: (2020) -
Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
por: Wang, Fangfang, et al.
Publicado: (2020) -
53BP1 regulates heterochromatin through liquid phase separation
por: Zhang, Lei, et al.
Publicado: (2022) -
Author Correction: 53BP1 regulates heterochromatin through liquid phase separation
por: Zhang, Lei, et al.
Publicado: (2022) -
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma: ATM, ATR and FA in lung carcinoma
por: Beumer, Jan H., et al.
Publicado: (2015)